Next 10 |
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations. WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding...
2024-02-05 16:55:17 ET Gainers: Semper Paratus Acquisition ( LGST ) +13% . Graphite ( GRPH ) +12% . Varonis Systems ( VRNS ) +8% . NXP Semiconductors ( NXPI ) +3% . Spruce Biosciences ( SPRB ) +3% . Losers: Sy...
2024-02-01 12:36:25 ET More on Semper Paratus Acquisition Corporation Financial information for Semper Paratus Acquisition Corporation Read the full article on Seeking Alpha For further details see: SPAC Semper Paratus shareholders okay merger with Tevogen Bio
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the...
2024-01-29 13:21:09 ET Gainers: Neximmune ( NEXI ) +94% . Palisade Bio PALI +83% . Rail Vision Ltd ( RVSN ) +68% . Revelation Biosciences ( REVB ) +54% . Mercurity Fintech Holding MFH +34% . J-Long Group Ltd JL +29% . Intelli...
2024-01-26 12:32:20 ET Gainers: Corbus Pharmaceuticals Holdings ( CRBP ) +300% . Aclarion ( ACON ) +66% . Panbela Therapeutics ( PBLA ) +36% . Inspire Veterinary Partners ( IVP ) +36% . Rail Vision Ltd ( RVSN ) +34% . Appfoli...
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement (“Prospectus Supplement”) to its defin...
The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders is an expected $1.2 billion. Tevogen Bio is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T...
2023-09-29 10:00:03 ET More on Semper Paratus Acquisition Corporation Financial information for Semper Paratus Acquisition Corporation For further details see: Semper Paratus Acquisition regains compliance with certain Nasdaq listing requirement
New York, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST, the “ Company ”) announced today that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) confirming...
News, Short Squeeze, Breakout and More Instantly...
Semper Paratus Acquisition Corporation Company Name:
LGST Stock Symbol:
NASDAQ Market:
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations. WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding...
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the...
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement (“Prospectus Supplement”) to its defin...